On the 24th local time, the Brazilian National Health Supervision Agency approved the emergency use of the new crown preventive drug Evusheld produced by the British pharmaceutical company AstraZeneca in the country. This is the seventh Covid-19 treatment drug approved in Brazil and the first preventive drug against Covid-19 approved in the country.
Brazil’s National Health Supervision Administration believes that the drug can play a certain preventive role in patients with defective immune systems who may become severely ill after infection with the new coronavirus, but at the same time emphasizes that the drug cannot replace vaccines.
According to the data of the Brazilian Ministry of Health, as of the evening of the 24th, the country has accumulated more than 28.57 million confirmed cases of new coronary pneumonia and more than 647,000 deaths. In the past 24 hours, Brazil recorded 93,757 new confirmed cases and 971 new deaths. (Headquarters reporter Yan Shu)
Source: CCTV News Client